Skip to main content
navy blue gradient

SUPPORT AND RESOURCES

SUPPORT YOU CAN COUNT ON

THE AMYLYX CARE TEAM (ACT)™ IS HERE TO HELP

The ACT Support Program is designed to help provide you with support as you start and continue on your RELYVRIOTM prescription that your doctor has prescribed.

 

Get personalized support from ACT

Once you and your doctor have decided that RELYVRIO is right for you, that’s when ACT comes in. When your doctor enrolls you in the ACT Support Program, they are helping you receive your prescription and personalized support throughout your treatment journey.

ACT team members are available to assist you Monday through Friday, 8:00 AM to 8:00 PM ET

ACT Team Member headshot

Heather
ACT Patient Support Services

Comprehensive financial assistance is available for eligible individuals

The Amylyx Care Team strives to find affordable solutions through 3 key programs:

$0 Co-Pay Program

$0 Co-Pay Program*

If you are commercially insured with private insurance (not Medicare or Medicaid or any other federal- or state-funded insurance program), you may be eligible for our co-pay assistance program. Your ACT Care Coordinator can help see if you qualify for a $0 co-pay.

Up to 2 months of RELYVRIO while you wait for insurance to approve

Interim Access Program

We can assess your eligibility to receive up to 2 months of RELYVRIO while you are waiting for your insurance company to approve your treatment. This program is available on a case-by-case basis if you’ve been prescribed RELYVRIO for the first time and are commercially insured.

ACT Patient Assistance Program may be able to help assist you if you don't have insurance

Patient Assistance Program

If you do not have insurance or do not have insurance that covers your treatment, the ACT Patient Assistance Program may be able to assist you. ACT team members can work with you to determine eligibility.

*Out-of-pocket costs related to medication, appointments, evaluations, testing, or other related services are not covered by the RELYVRIO Co-Pay Program. The RELYVRIO Co-Pay Program is not available for prescriptions purchased under Medicare, Medicaid, TRICARE, or other federal- and state-funded programs. Amylyx reserves the right to amend or terminate the Program at any time without notice. Co-pay amounts after applying co-pay assistance may depend on the patient’s insurance plan and may vary. The RELYVRIO Co-Pay Program is intended to help individuals afford RELYVRIO.

Find out more about the ACT Support Program

Visit ACT Now

RESOURCES TO HELP YOU LEARN MORE

RELYVRIO Overview Brochure Resource

RELYVRIO Overview Brochure

More information about treatment with RELYVRIO

What to Expect Resource

What to Expect

A handy guide to getting started with RELYVRIO

Directions for Use Resource

Directions for Use

A convenient reference for taking RELYVRIO

RELYVRIO Frequently Asked Questions Resource

RELYVRIO FAQs

Answers to frequently asked questions about RELYVRIO

Community Webinar Video Thumbnail

Community Webinar

A recording of a live webinar for the ALS community

ACT Brochure Resource

ACT Brochure

Useful information about the Amylyx Care Team (ACT)

Medication Guide Resource

Medication Guide

Important information on RELYVRIO

STAY IN THE KNOW

Fill out the form below to stay informed and receive the latest information on RELYVRIO.

Thank you

A HEARTFELT THANKS

 

Amylyx wants to thank all of you in the ALS community, including clinical trial participants, their families, investigators, sites of the trial, and individuals who have given us feedback along the way. We’re dedicated to representing the ALS community in everything we do. We know that we couldn’t have achieved any of this without you.

IMPORTANT SAFETY INFORMATION

Before you receive RELYVRIO, tell your doctor about all of your medical conditions, including if you:

  • Have pancreas, liver, or intestinal problems
  • Have heart failure, including congestive heart failure
  • Have high blood pressure
  • Have kidney problems
  • Are pregnant or plan to become pregnant. It is not known if RELYVRIO will harm your unborn baby
  • Are breastfeeding or plan to breastfeed. It is not known if RELYVRIO passes into your breast milk. You and your doctor should decide the best way to feed your baby

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements and any taurursodiol products, such as tauroursodeoxycholic acid (TUDCA).

RELYVRIO may affect the way other medicines work, and other medicines may affect how RELYVRIO works.

What are the possible side effects of RELYVRIO?

RELYVRIO may cause serious side effects, including:

  • Changes in bile acid levels. RELYVRIO may increase bile acid levels and cause worsening diarrhea if you already have problems with your liver, bile ducts, or pancreas. Your doctor should monitor you for these side effects. Some disorders of the pancreas, bile ducts, or intestines may also make it harder to absorb RELYVRIO
  • Salt (sodium) retention. RELYVRIO contains a high amount of salt. For people who are sensitive to salt intake, such as people with heart failure, high blood pressure, or kidney problems, limit the amount of salt you eat and drink. Talk to your doctor about the total amount of daily salt that is right for you. Your doctor will monitor you for signs and symptoms of salt retention during your treatment with RELYVRIO

The most common side effects of RELYVRIO include diarrhea, abdominal pain, nausea, and upper respiratory tract infection.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of RELYVRIO. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

INDICATION

RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults.

For additional information about RELYVRIO, please see the full Prescribing Information and Medication Guide.

IMPORTANT SAFETY INFORMATION

Before you receive RELYVRIO, tell your doctor about all of your medical conditions, including if you:

  • Have pancreas, liver, or intestinal problems
  • Have heart failure, including congestive heart failure
  • Have high blood pressure
  • Have kidney problems
  • Are pregnant or plan to become pregnant. It is not known if RELYVRIO will harm your unborn baby
  • Are breastfeeding or plan to breastfeed. It is not known if RELYVRIO passes into your breast milk. You and your doctor should decide the best way to feed your baby

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements and any taurursodiol products, such as tauroursodeoxycholic acid (TUDCA).

RELYVRIO may affect the way other medicines work, and other medicines may affect how RELYVRIO works.

What are the possible side effects of RELYVRIO?

RELYVRIO may cause serious side effects, including:

  • Changes in bile acid levels. RELYVRIO may increase bile acid levels and cause worsening diarrhea if you already have problems with your liver, bile ducts, or pancreas. Your doctor should monitor you for these side effects. Some disorders of the pancreas, bile ducts, or intestines may also make it harder to absorb RELYVRIO
  • Salt (sodium) retention. RELYVRIO contains a high amount of salt. For people who are sensitive to salt intake, such as people with heart failure, high blood pressure, or kidney problems, limit the amount of salt you eat and drink. Talk to your doctor about the total amount of daily salt that is right for you. Your doctor will monitor you for signs and symptoms of salt retention during your treatment with RELYVRIO

The most common side effects of RELYVRIO include diarrhea, abdominal pain, nausea, and upper respiratory tract infection.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of RELYVRIO. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

INDICATION

RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults.

For additional information about RELYVRIO, please see the full Prescribing Information and Medication Guide.